SBS Dateline: How Pam’s son unknowingly took a drug that killed him

Graphic of one woman overlayed on another

As overdose deaths continue to climb in the US and Canada, driven by fentanyl and other synthetic substances in the unregulated drug market, a growing number of community groups are calling for safe supply. Penington Institute CEO John Ryan spoke to reporter Sophie Bennett about what implications the North American crisis might have for Australia. […]

Welcome commitment from Australian Government to improve patient access to essential medicines for opioid dependence treatment

Penington Institute

Penington Institute firmly welcomes the announcement in the 2023-24 Budget that the Australian Government will commit $377.3 million dollars over 4 years to improving access to opioid dependence treatment medicines under the Pharmaceutical Benefits Scheme (PBS). This commitment will significantly improve affordability and access to these essential medicines for tens of thousands of Australians. From […]

Announcement of the Passing of Emeritus Professor David Penington AC

David Penington AC

Penington Institute’s namesake and patron, Emeritus Professor David Penington AC, passed away on 6 January 2023. Professor Penington was one of Australia’s leading public intellectuals and health experts. He courageously advocated for sensible policy in his roles as former chair of the National AIDS Task Force, the Victorian Premier’s Drug Advisory Council, and the Victorian […]

December 2022 | VOL. 19, ED. 6

The Bulletin December 2022

Colour PDF Greyscale PDF In this issue Pharmacotherapy: “April”, opioid agonist treatment Integrated Care: Tess Mungovan, QuIHN Residential Rehab: Catherine Coles, CAAPS Q&A: “Zoe”, living experience

November 2022 | VOL. 19, ED. 5

The Bulletin Cover

Colour PDF Greyscale PDF In this issue Cloud of Confusion: vaping as harm minimisation Prison & Performance Drugs, Disability & the NDIS Q&A Dr Mary Ellen Harrod

October 2022 | VOL. 19, ED. 4

The Bulletin October 2022

Colour PDF Greyscale PDF In this issue Injecting in NSP-Adjacent Public Facilities CanTEST: Early Findings from Australia’s Flagship Drug-Checking Service Q&A with Professor James Ward Nitrous Oxide | Are ‘nangs’ cause for concern?

September 2022 | VOL. 19, ED. 3

The Bulletin September

Colour PDF Greyscale PDF In this issue Removing the Barriers to Access Q&A with Kirsten Horsburgh Australia: Hep C-Free by 2030? Interrogating the Gender Gap in Overdose Deaths